ABT Aqua Bio Technology

Aqua Bio Technology ASA: Employees buy shares

Aqua Bio Technology ASA: Employees buy shares

Acting CEO Espen Kvale, CTO Hans Kristian Leren and BDM Vigdis Tuft Heinimann have today purchased 950,000 shares in total in Aqua Bio Technology ASA (ABT) from main shareholders Finnvik Eiendom AS, a company controlled by board member Roger Hofseth, and board member Jan Pettersson, at a price per share of NOK 2.15.

Espen Kvale has purchased 250,000 shares in the Company from each of Finnvik Eiendom AS and Jan Pettersson, corresponding to a total purchase of 500,000 shares, through his wholly owned holding company EK Holding Invest AS (under incorporation). Following this purchase, Espen Kvale holds 500,000 shares in the Company, corresponding to an ownership stake of 3.25% of the total outstanding shares in the Company.

Hans Kristian Leren has purchased 125,000 shares in the Company from each of Finnvik Eiendom AS and Jan Petterson, corresponding to a total purchase of 250,000 shares. Following this purchase, Hans Kristian Leren holds 250,000 shares in the Company, corresponding to an ownership stake of 1.63% of the total outstanding shares in the Company.

Vigdis Tuft Heinimann has purchased 100,000 shares in the Company from each of Finnvik Eiendom AS and Jan Petterson, corresponding to a total purchase of 200,000 shares. Following this purchase, Vigdis Tuft Heinimann holds 200,000 shares in the Company, corresponding to an ownership stake of 1.30% of the total outstanding shares in the Company.

Following these sales, Roger Hofseth and associated parties holds 3,212,000 shares in the Company, corresponding to an ownership stake of 20.90% of the total outstanding shares in the Company.

Following these sales, Jan Pettersson and associated parties holds 3,295,000 shares in the Company, corresponding to an ownership stake of 21.12% of the total outstanding shares in the Company.

For further information, please contact Espen Kvale, acting CEO, telephone or .

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on the Axess market of the Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act.

EN
20/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aqua Bio Technology

 PRESS RELEASE

Aqua Bio Technology ASA: Safety studies of 6 products from the product...

Aqua Bio Technology ASA: Safety studies of 6 products from the product series Balance & Vitality completed and approved Aqua Bio Technology ASA: Safety studies of 6 products from the product series Balance & Vitality completed and approvedReference is made to the stock exchange announcement of regarding ongoing safety studies for the Nordic Beauty and Balance & Vitality product series. We have today received confirmation that the first 6 products from Balance & Vitality have passed the safety studies that the EU requires to be carried out before commercialization. The results for further 1...

 PRESS RELEASE

Aqua Bio Technology ASA: Sikkerhetsstudier av 6 produkter fra produkts...

Aqua Bio Technology ASA: Sikkerhetsstudier av 6 produkter fra produktserien Balance & Vitality fullført og godkjent Det vises til børsmelding av vedrørende pågående sikkerhetsstudier for produktseriene Nordic Beauty og Balance & Vitality. ABT har mottatt bekreftelse på at de 6 første produktene fra Balance & Vitality serien har passert sikkerhetsstudier som EU krever gjennomført før kommersialisering. Resultatene for ytterligere 18 produkter forventes i løpet av januar i 2021, mens de siste 3 produktene som kompletterer serien forventes godkjent i løpet av Q1. Balance & Vitality vil være e...

 PRESS RELEASE

Aqua Bio Technology ASA: Hydrafacial has entered into partnership with...

Aqua Bio Technology ASA: Hydrafacial has entered into partnership with Restorsea - Conversion Lab launches Veritas MD platform Restorsea's commercialization of Aqua Bio Technologies ASA's hatching fluid ingredient (Aquabeautine XL) continues. As mentioned in the commercial update on November 26, 2020, Restorsea has recently entered into two license agreements with two partners in addition to the license agreement with NASDAQ-listed Conversion Labs. In connection with Hydrafacial`s merger with Vesper Healthcare and the contemplated listing on (NASDAQ), Restorsea is presented as . In Q3 20...

 PRESS RELEASE

Aqua Bio Technology ASA: Hydrafacial har inngått samarbeid med Restors...

Aqua Bio Technology ASA: Hydrafacial har inngått samarbeid med Restorsea – Conversion Lab lanserer Veritas MD plattform Restorseas kommersialisering av Aqua Bio Technologys ASAs klekkeveskeingrediens (Aquabeautine XL) fortsetter. Som nevnt i kommersiell oppdatering 26. november 2020, har Restorsea nylig inngått to lisensavtaler med to partnere i tillegg til lisensavtalen med NASDAQ-noterte Conversion Labs. I forbindelse med Hydrafacial`s fusjon med Vesper Healthcare og den planlagte noteringen på (NASDAQ), presenteres Restorsea som . Hydrafacial opplyser at selskapet per Q3 2020 har utpl...

 PRESS RELEASE

Aqua Bio Technology ASA: Acquisition of Moana Skincare completed - dis...

Aqua Bio Technology ASA: Acquisition of Moana Skincare completed - distribution agreement for New Zealand and Australia close Reference is made to where it is informed that Aqua Bio Technology ASA (ABT) is acquiring all rights to Moana Skincare . This acquisition has now been completed and in the near future ABT expects to enter into a three-year agreement for the distribution of Moana products in New Zealand and Australia. Moana Skincare currently consists of a portfolio of 19 skin care products, most of which are based on potent extracts from plants found in New Zealand's unspoiled na...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch